Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers

No abstract is available for this paper.

• Publication year

  2020

• Venue

  medRxiv

• Publication date

  2020-06-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1101/2020.06.09.20116806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Remdesivir for the Treatment of Covid-19 - Preliminary Report.

  2020cited by this paper
• A pneumonia outbreak associated with a new coronavirus of probable bat origin

  2020cited by this paper
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

  2020cited by this paper
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

  2020cited by this paper
• In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

  2020cited by this paper
• Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

  2020cited by this paper
• A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

  2020cited by this paper
• Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19

  2020cited by this paper
• Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

  2020cited by this paper
• Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

  2020cited by this paper
• RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

  2020cited by this paper
• Remdesivir for the Treatment of Covid-19 — Final Report

  2020cited by this paper
• Emerging Pharmaceutical Treatments of Novel COVID-19: A Review

  2020cited by this paper
• Faculty Opinions recommendation of Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.

  2020cited by this paper
• Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19

  2020cited by this paper
• Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020

  2020cited by this paper
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool

  2019cited by this paper
• Expanding the activity spectrum of antiviral agents.

  2019cited by this paper
• Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases

  2017cited by this paper
• Composition and distribution of the health workforce in India: estimates based on data from the National Sample Survey

  2016cited by this paper
• Influenza A (H1N1)

  2016cited by this paper
• Reconstitution of the receptor-binding motif of the SARS coronavirus

  2015cited by this paper
• Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+ Endolysosomes Is a Rate-Defining Step

  2014cited by this paper
• Chloroquine Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Lysosomal Bone Morphogenetic Protein Type II Receptor Degradation

  2013cited by this paper
• Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?

  2012cited by this paper
• Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model

  2012cited by this paper
• Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.

  2007cited by this paper
• Virology Journal BioMed Central

  2005cited by this paper
• What’s new in the renin-angiotensin system?

  2004cited by this paper
• Effects of chloroquine on viral infections: an old drug against today's diseases

  2003cited by this paper
• Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate.

  1983cited by this paper

• HCQ for COVID-19: real-time meta analysis of 273 studies

  2021cites this paper
• Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs

  2021cites this paper
• Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers - A Multicentric Cohort Study Assessing Effectiveness and Safety.

  2021cites this paper
• Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis

  2021cites this paper
• FOR EMERGENCY USE AUTHORIZATION On behalf of Dr ,

  2021cites this paper
• Hydroxychloroquine as post-exposure prophylaxis for Covid-19: Why simple data analysis can lead to the wrong conclusions from well-designed studies

  2021cites this paper
• Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients

  2021cites this paper
• HCQ is effective for COVID-19 when used early : real-time meta analysis of 205 studies

  2021influential citation
• Effective post-exposure prophylaxis of Covid-19 is associated with use of hydroxychloroquine: Prospective re-analysis of a public dataset incorporating novel data.

  2020cites this paper
• The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.

  2020cites this paper
• A study on stigma and apprehensions related to COVID-19 among healthcare professionals in Delhi

  2020cites this paper
• Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review

  2020cites this paper
• The Role of Hydroxychloroquine in the Age of COVID-19: A Periodic Systematic Review and Meta-Analysis

  2020influential citation
• The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis

  2020cites this paper
• Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 30 October 2020

  2020cites this paper
• THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A REVIEW OF MECHANISMS AND EVIDENCE

  2020cites this paper
• Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety

  2020cites this paper
• Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen

  2020cites this paper
• Preventing disease after exposure to COVID-19 using hydroxychloroquine: A summary of a protocol for exploratory re-analysis of age and time-nuanced effects.

  2020cites this paper
• COVID-19 in Healthcare Workers: A Living Systematic Review and Meta-analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes

  2020cites this paper
• Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)

  2020cites this paper
• Antivirals for COVID-19 in Solid Organ Transplant Recipients

  2020cites this paper
• Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19

  2020cites this paper